Associated Papers
First identification of the rare FH-Q185R germline mutation in a Chinese HLRCC patient: A case report and literature review.
Zhang L et al.
Sage Open Medical Case Reports, 2026
Fumarate hydratase-deficient renal cell carcinoma: a single institution-based study of 29 patients by clinicopathological, immunohistochemical and genetic approaches.
Lee S et al.
Pathology, 2025
Benign metastasizing fumarate hydratase (FH)-deficient uterine leiomyomas: clinicopathological and molecular study with first documentation of multi-organ metastases.
Yin X et al.
Virchows Archiv : an International Journal of Pathology, 2024
Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
Alam NA et al.
The Journal of Molecular Diagnostics : Jmd, 2005
Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
Chan I et al.
Clinical and Experimental Dermatology, 2005
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.
Alam NA et al.
Human Molecular Genetics, 2003
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson IP et al.
Nature Genetics, 2002
Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma.
Othman A et al.
Case Reports in Oncology, 0
Select a paper to view details